Healthcare -
Biotechnology - NASDAQ - US
$ 45.74
-2.66 %
$ 5.4 B
Market Cap
-8.5
P/E
CYTK - STOCK-BASED COMPENSATION
Stock-based Compensation CYTK - Cytokinetics, Incorporated
72.1 M
LAST VALUE
63.88%
2 YEAR CAGR
49.16%
5 YEAR CAGR
34.95%
10 YEAR CAGR